Rare live birth to a 48-year-old woman after embryo transfer with autologous oocyte: A case report

Taiwan J Obstet Gynecol. 2022 May;61(3):551-554. doi: 10.1016/j.tjog.2022.03.028.

Abstract

Objective: Advanced maternal age and decreased ovarian reserve have been challenges for assisted reproductive technology (ART). Few cases, using autologous oocytes more than 46-years-old, have previously been reported. We seek to show how the age at which autologous oocytes may successfully be employed may be increasing.

Case report: We report a 47-year-old woman with an anti-Müllerian hormone (AMH) level of 0.24 ng/mL, conceived through in vitro fertilization (IVF) using autologous oocytes. Patient was given an antagonist protocol for ovarian stimulation and one frozen-thawed embryo was transferred. The patient became pregnant. The course of her pregnancy was uneventful and she gave birth to a 3330 gm male baby by cesarean section.

Conclusion: Technological advances permit women, who previously would have been considered too old to employ an autologous oocyte, to have a successful pregnancy with a live birth.

Keywords: Autologous; Embryo; Frozen-thawed; In vitro fertilization; Oocytes.

Publication types

  • Case Reports

MeSH terms

  • Cesarean Section
  • Embryo Transfer / adverse effects
  • Embryo Transfer / methods
  • Female
  • Fertilization in Vitro / adverse effects
  • Fertilization in Vitro / methods
  • Humans
  • Live Birth*
  • Male
  • Oocyte Retrieval* / adverse effects
  • Oocytes
  • Pregnancy
  • Retrospective Studies